Status:
COMPLETED
The Comparison of Remimazolam With Propofol in Core Body Temperature
Lead Sponsor:
Wonkwang University Hospital
Conditions:
Hypothermia; Anesthesia
Eligibility:
MALE
19-75 years
Phase:
PHASE4
Brief Summary
1. Core body temperature is normally tightly regulated to within a few tenths of a degree. The major thermoregulatory defences in humans are sweating, arteriovenous shunt vasoconstriction, and shiveri...
Detailed Description
1. When propofol induces anesthesia, blood pressure decreases due to vasodilation, which is due to direct action on vascular smooth muscle and vasodilation due to blockage of the sympathetic nervous s...
Eligibility Criteria
Inclusion
- ASA physical classification I-III,
- Patients who undergoing Robotic-assisted or laparoscopic (LRP) radical prostatectomy.
Exclusion
- Patients who have Medications or any implanted device that could affect cardiovascular function
- Patients who have a history with heat imbalance, thyroid diseases, dystautonomia, Raynaud's syndrome, uncontrolled diabetes mellitus, or hypertension.
Key Trial Info
Start Date :
March 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2021
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT05215834
Start Date
March 1 2021
End Date
November 30 2021
Last Update
February 14 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wonkwag UH
Iksan, South Korea, 54538